Kathryn E. Wengel - Nov 9, 2022 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
EVP, Chief GSC Officer
Signature
Raavi K. Deol, as attorney-in-fact for Kathryn E. Wengel
Stock symbol
JNJ
Transactions as of
Nov 9, 2022
Transactions value $
-$1,655,392
Form type
4
Date filed
11/10/2022, 03:47 PM
Previous filing
Jun 14, 2022
Next filing
Feb 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $1.19M +16.4K +23.01% $72.54 87.7K Nov 9, 2022 Direct
transaction JNJ Common Stock Sale -$2.85M -16.4K -18.71% $173.42 71.3K Nov 9, 2022 Direct F1
holding JNJ Common Stock 52 Nov 9, 2022 By 401k F2
holding JNJ Common Stock 281 Nov 9, 2022 By ESOP F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Employee Stock Options (Right to Buy) Options Exercise $0 -16.4K -100% $0.00* 0 Nov 9, 2022 Common Stock 16.4K $72.54 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $173.41 to $173.45. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 Shares held in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (10/31/2022).
F3 Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (10/31/2022).